(Q46219342)

20 December 2017

title

Tumoral amyloidosis of bone of beta 2-microglobulin origin in association with long-term hemodialysis: a new type of amyloid disease (English)

1 reference

20 December 2017

1 reference

Casey TT

1

1 reference

20 December 2017

Stone WJ

2

1 reference

20 December 2017

DiRaimondo CR

3

1 reference

20 December 2017

Brantley BD

4

1 reference

20 December 2017

DiRaimondo CV

5

1 reference

20 December 2017

Gorevic PD

6

1 reference

20 December 2017

Page DL

7

1 reference

20 December 2017

language of work or name

English

0 references

publication date

1 July 1986

1 reference

20 December 2017

published in

Human Pathology

1 reference

20 December 2017

volume

17

1 reference

20 December 2017

issue

7

1 reference

20 December 2017

page(s)

731-738

1 reference

20 December 2017

Bone lesions in primary systemic amyloidosis. A report of a case

cites work

1 reference

https://api.crossref.org/works/10.1016/S0046-8177(86)80183-6

7 January 2021

Bone lesions in primary amyloidosis

1 reference

https://api.crossref.org/works/10.1016/S0046-8177(86)80183-6

7 January 2021

Pathologic hip fractures secondary to amyloidoma. Case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016/S0046-8177(86)80183-6

7 January 2021

Amyloid lesions of bone

1 reference

https://api.crossref.org/works/10.1016/S0046-8177(86)80183-6

7 January 2021

Amyloid-producing plasmacytoma of the pelvis. Case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016/S0046-8177(86)80183-6

7 January 2021

Clinicopathological importance of deposits of amyloid in the femoral head

1 reference

https://api.crossref.org/works/10.1016/S0046-8177(86)80183-6

7 January 2021

Pathologic fractures associated with idiopathic amyloidosis of bone in chronic hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016/S0046-8177(86)80183-6

7 January 2021

Lack of evidence for protein AA reactivity in amyloid deposits of lattice corneal dystrophy and amyloid corneal degeneration.

1 reference

https://api.crossref.org/works/10.1016/S0046-8177(86)80183-6

7 January 2021

Beta-2 microglobulin is an amyloidogenic protein in man.

1 reference

https://api.crossref.org/works/10.1016/S0046-8177(86)80183-6

7 January 2021

Appearance of systemic amyloidosis in a chronic hemodialysis patient

1 reference

https://api.crossref.org/works/10.1016/S0046-8177(86)80183-6

7 January 2021

Erosive azotemic osteoarthropathy: possible role of amyloidosis.

1 reference

https://api.crossref.org/works/10.1016/S0046-8177(86)80183-6

7 January 2021

Synovial amyloidosis in patients undergoing long-term hemodialysis

1 reference

https://api.crossref.org/works/10.1016/S0046-8177(86)80183-6

7 January 2021

Deposition of an amyloid-like substance as a possible complication of regular dialysis treatment

1 reference

https://api.crossref.org/works/10.1016/S0046-8177(86)80183-6

7 January 2021

A new form of amyloid protein associated with chronic hemodialysis was identified as beta 2-microglobulin

1 reference

https://api.crossref.org/works/10.1016/S0046-8177(86)80183-6

7 January 2021

β 2 -Microglobulin—A Free Immunoglobulin Domain

1 reference

https://api.crossref.org/works/10.1016/S0046-8177(86)80183-6

7 January 2021

β2-Microglobulin levels in cancerous and other disease states

1 reference

https://api.crossref.org/works/10.1016/S0046-8177(86)80183-6

7 January 2021

Isolation and purification of human serum beta 2-microglobulin from the hemodialysis ultrafiltrate of patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1016/S0046-8177(86)80183-6

7 January 2021

Amyloid joint disease

1 reference

https://api.crossref.org/works/10.1016/S0046-8177(86)80183-6

7 January 2021

10.1016/S0046-8177(86)80183-6

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017